Cargando…
Sodium-glucose cotransporter 2 inhibitors and heart failure: the best timing for the right patient
Sodium-glucose cotransporter 2 inhibitors (SGLT2i), initially born as anti-diabetic drugs, have shown many beneficial effects on the cardiovascular system, in particular against heart failure (HF). HF is a complex and multifaceted disease that requires a comprehensive approach. It should not be cons...
Autores principales: | Severino, Paolo, D’Amato, Andrea, Prosperi, Silvia, Costi, Bettina, Angotti, Danilo, Birtolo, Lucia Ilaria, Chimenti, Cristina, Lavalle, Carlo, Maestrini, Viviana, Mancone, Massimo, Fedele, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10140096/ https://www.ncbi.nlm.nih.gov/pubmed/34654997 http://dx.doi.org/10.1007/s10741-021-10170-1 |
Ejemplares similares
-
Myocardial Tissue Characterization in Heart Failure with Preserved Ejection Fraction: From Histopathology and Cardiac Magnetic Resonance Findings to Therapeutic Targets
por: Severino, Paolo, et al.
Publicado: (2021) -
Ischemic Heart Disease and Heart Failure: Role of Coronary Ion Channels
por: Severino, Paolo, et al.
Publicado: (2020) -
Potential Role of eNOS Genetic Variants in Ischemic Heart Disease Susceptibility and Clinical Presentation
por: Severino, Paolo, et al.
Publicado: (2021) -
Ischemic Heart Disease Pathophysiology Paradigms Overview: From Plaque Activation to Microvascular Dysfunction
por: Severino, Paolo, et al.
Publicado: (2020) -
Telemedicine: an Effective and Low-Cost Lesson From the COVID-19 Pandemic for the Management of Heart Failure Patients
por: Severino, Paolo, et al.
Publicado: (2023)